AESKU.BION - Viral Antigen Substrate Slides

  • Each lot is tested with a panel of titered sera to ensure sensitivity lot to lot.
  • Both Positive and Negative cells are in each well to provide a built-in control.
  • Most substrates can be used for the detection of IgG or IgM antibodies.

 

Instructions for use (ZIP file Download | 7.84 MB)

 

 Code Number
 Product Name
Product Description
Size
AD-3112
Adenovirus
The AESKU.BION ADENOVIRUS ANTIGEN SUBSTRATE SLIDES may be used as the antigenic substrate in indirect fluorescent antibody assays for the qualitative and/or semi-quantitative determination of Adenovirus antibodies in human serum. Intended for use as an aid in the diagnosis of active infection and as a determination of immunological experience with Adenovirus.
12-well
CB-3312 (12-well)
CB-3306 (6-well)
Coxsackievirus Group B Screen
(Each well contains mixture of Coxsackievirus
B1, B2, B3, B4, B5, B6)
The AESKU.BION COXSACKIEVIRUS B ANTIGEN SUBSTRATE SLIDES may be used as the antigenic substrate in indirect fluorescent antibody assays for the qualitative and/or semi-quantitative determination of Coxsackievirus B antibodies in human serum. Intended for use as an aid in the diagnosis of active infection and as a
determination of immunological experience with Coxsackievirus B.
12-well and 6-well
CM-2012
Cytomegalovirus
The AESKU.BION CYTOMEGALOVIRUS (CMV) ANTIGEN SUBSTRATE SLIDES may be used as the antigenic substrate in indirect fluorescent antibody assays for the qualitative and/or semi-quantitative determination of Cytomegalovirus lgG or lgM
antibodies in human serum. Intended for use as an aid in the diagnosis of primary infection, re-infection or reactivation of the latent virus and as a determination of immunological experience with CMV. Not intended for use by blood banks for blood donor screening.
12-well
EC-4412
Echovirus Screen
(Each well contains a
mixture of Echovirus 4,
6, 9, 11, 30, and 34)
The AESKU.BION ECHOVIRUS ANTIGEN SUBSTRATE SLIDES may be used as the antigenic substrate in indirect fluorescent antibody assays for the qualitative and/or semi-quantitative determination of Echovirus antibodies in human serum. Intended for use as an aid in the diagnosis of active infection and as a determination of immunological experience with Echovirus.
12-well
EB-5012
Epstein-Barr Virus (EBV), VCA
The AESKU.BION EBV-VCA ANTIGEN SUBSTRATE SLIDES may be used as the antigenic substrate in indirect fluorescent antibody assays for the qualitative and/or semi-quantitative determination of lgG or lgM EBV-VCA antibodies in human serum. Intended for use as an aid in the diagnosis of primary infection (Infectious Mononucleosis), re-infection or reactivation of the latent virus and as a determination of immunological experience with EBV.
12-well
HS1-3012
Herpes Simplex Virus Type 1
The AESKU.BION HSV-1 (Herpes Simplex Virus Type 1) ANTIGEN SUBSTRATE SLIDES may be used as antigenic substrates in indirect fluorescent antibody assays for the qualitative and/or semi-quantitative determination of HSV lgG or lgM antibodies in human serum. Intended for use as an aid in the diagnosis of primary infection, reinfection or reactivation of the latent virus and as a determination of immunological experience with HSV.
12-well
HS2-4012
Herpes Simplex Virus Type 2
The AESKU.BION HSV-2 (Herpes Simplex Virus Type 2) ANTIGEN SUBSTRATE SLIDES may be used as antigenic substrates in indirect fluorescent antibody assays for the qualitative and/or semi-quantitative determination of HSV lgG or lgM antibodies in human serum. Intended for use as an aid in the diagnosis of primary infection, reinfection or reactivation of the latent virus and as a determination of immunological experience with HSV.
12-well
HHV6-4312
Human Herpesvirus Type 6
The AESKU.BION HUMAN HERPESVIRUS type 6 ANTIGEN SUBSTRATE SLIDES are for Research Use Only.
12-well
IA-1112
Influenza A Virus
The AESKU.BION INFLUENZA A VIRUS ANTIGEN SUBSTRATE SLIDES may be used as the antigenic substrate in indirect fluorescent antibody assays for the qualitative and/or semi-quantitative determination of Influenza A antibodies in human serum. Intended for use as an aid in the diagnosis of active infection and as a determination of immunological experience with Influenza A virus.
12-well
IB-2112
Influenza B Virus
The AESKU.BION INFLUENZA B VIRUS ANTIGEN SUBSTRATE SLIDES may be used as the antigenic substrate in indirect fluorescent antibody assays for the qualitative and/or semi-quantitative determination of Influenza B antibodies in human serum. Intended for use as an aid in the diagnosis of active infection and as a determination of immunological experience with Influenza B virus.
12-well
ME-6012
Measles (Rubeola) Virus
The AESKU.BION MEASLES (RUBEOLA) VIRUS ANTIGEN SUBSTRATE SLIDES may be used as the antigenic substrate in indirect fluorescent antibody assays for the qualitative and/or semi-quantitative determination of Measles (Rubeola) Virus lgG or lgM antibodies in human serum. Intended for use as an aid in the diagnosis of primary infection and as a determination of immunological experience with Measles Virus.
12-well
MU-8012
Mumps Virus
The AESKU.BION MUMPS VIRUS ANTIGEN SUBSTRATE SLIDES may be used as the antigenic substrate in indirect fluorescent antibody assays for the qualitative and/or semi-quantitative determination of Mumps Virus lgG or lgM antibodies in human serum. Intended for use as an aid in the diagnosis of primary infection and as a determination of immunological experience with Mumps Virus.
12-well
RS-9012
Respiratory Syncytial Virus
The AESKU.BION RESPIRATORY SYNCYTIAL VIRUS ANTIGEN SUBSTRATE SLIDES may be used as the antigenic substrate in indirect fluorescent antibody assays for the qualitative and/or semi-quantitative determination of Respiratory Syncytial Virus antibodies in human serum. Intended for use as an aid in the diagnosis of active infection and as a determination of immunological experience with Respiratory Syncytial Virus.
12-well
VZ-7012
Varicella-Zoster Virus
The AESKU.BION VARICELLAZOSTER VIRUS ANTIGEN SUBSTRATE SLIDES may be used as the antigenic substrate in indirect immunoassay systems for the qualitative and/or semi-quantitative determination of Varicella-Zoster Virus (VZV) lgG or lgM antibodies in human serum. Intended for use as an aid in the diagnosis of primary infection, reinfection, or reactivation of the latent virus and as a determination of immunological experience with VZV.
12-well